检索结果 - F.S. Ferrandi

  • Showing 1 - 1 results of 1
Refine Results
  1. 1

    P078 | A SIGNIFICANT DOSE REDUCTION OF VENETOCLAX DOES NOT AFFECT RESPONSE RATE AND OVERALL SURVIVAL OF AML PATIENTS NOT ELIGIBLE FOR INTENSIVE CHEMOTHERAPY 由 E. Inzoli, S.C. Dalto, A. Romanelli, F.S. Ferrandi, G. Galassi, V. Montefusco.

    发表在 Haematologica (2025-09-01)
    获取全文
    文件


检索工具: